Tag: Psychosis

According to the Centers for Disease Control and Prevention, approximately 13.2% of American adults take antidepressants, but few will ever experience the rare and unsettling side effect of hallucinations. This article explains the potential link between some anti-depression pills and hallucinations, exploring the contributing factors and crucial steps to take if this occurs.

Lamotrigine, sold under the brand name Lamictal, is an anticonvulsant primarily approved for treating bipolar depression and seizures, not for psychosis. Therefore, the question, **Can Lamictal help with psychosis?**, has a complex and nuanced answer, as its potential role is often indirect, limited to specific situations, and supported by conflicting evidence.

An estimated 1.6% of U.S. adults use antipsychotic medications, which are crucial for managing psychosis [1.7.1]. When determining 'What is the strongest antipsychotic for psychosis?', it is essential to distinguish between potency and efficacy, with clozapine recognized for its superior effectiveness in treatment-resistant cases [1.2.1, 1.2.3].

According to some research, as many as 51% of individuals experiencing a first psychotic episode also have a co-occurring substance use disorder, highlighting a significant link. Answering **what drug most commonly causes psychosis?** is complicated, as the likelihood and presentation of drug-induced psychosis depend heavily on the type of substance, dosage, frequency of use, and individual susceptibility.

While levetiracetam (Keppra) is generally well-tolerated, psychiatric side effects occur in up to 13.3% of adults taking the medication, with psychosis being a rare but recognized adverse reaction. This article explores the link between Keppra and psychosis, outlining the known risks and symptoms associated with this serious side effect.

Case reports in medical literature have documented psychosis, including hallucinations and delusions, as a rare adverse effect associated with the use of lamotrigine (brand name Lamictal). While the drug is widely used and well-tolerated for treating epilepsy and bipolar disorder, clinicians and patients should be aware of this potential, albeit uncommon, side effect.

According to research published in the *Journal of Clinical Neuropharmacology*, antidepressants have been previously associated with paranoid reactions in psychiatric patients, highlighting the fact that **can antidepressants worsen paranoia** in some susceptible individuals. While uncommon, this paradoxical effect requires careful consideration during treatment planning and monitoring.

While a mild increase in serotonin often improves mood, a severe excess can trigger a potentially life-threatening condition called Serotonin Syndrome, which includes psychosis-like symptoms such as hallucinations and delirium. This complex relationship illustrates how an imbalance in this crucial neurotransmitter can profoundly impact mental state.

While levetiracetam is generally well-tolerated, psychiatric and behavioral side effects occur in up to 22% of patients, presenting a significant consideration for clinicians and patients. This article explores **what are the psychological effects of levetiracetam**, the factors that influence their occurrence, and how they can be managed.

While antipsychotics are a foundational treatment for psychosis, a growing body of evidence suggests a paradoxical effect may occur, particularly with long-term use. This phenomenon, known as dopamine supersensitivity psychosis (DSP), challenges the conventional understanding of these medications.